Teva creates generic version of J&J’s Risperdal
NORTH WALES, Pa. Teva Pharmaceuticals has introduced a generic version of Johnson & Johnson’s Risperdal oral solution, the Israeli generic drug maker’s United States subsidiary announced Friday.
The drug is used to treat schizophrenia. Teva?s version, risperidone oral solution, will be available in 30 mL bottles in the 1 mg per mL strength.
The branded version of the drug had sales of $2.2 billion in 2007, according to J&J financial data.
AstraZeneca announces plans to lay off 6,000 employees by 2013
NEW YORK Drug maker AstraZeneca plans to lay off 6,000 employees by 2013, the Anglo-Swedish company announced Thursday.
The layoffs add to the 9,000 jobs AstraZeneca said it would cut in 2007. The company has 65,000 employees.
Amid the worldwide economic downturn, several drug makers have announced layoffs. Pfizer announced this week that it would lay off more than 8,000 workers as part of its acquisition of Wyeth.
Bartell Drugs to offer free health screenings at 11 of its stores in Feb.
SEATTLE Bartell Drugs, which operates stores in the Seattle area, said it would offer free health screenings at 11 of its stores next month. The stores will offer tests for blood glucose, cholesterol and blood pressure in partnership with One Touch, Nature Made and CIA Health Screenings. Customers will receive results immediately.
“We are extremely pleased to offer these screenings, because the results can provide our customers with important front-line indicators in the fight against diabetes, heart disease and stroke,” chairman and CEO George Bartell said in a statement.
The screenings will take place from 10 a.m. to 4 p.m. every day of the month starting Feb. 16.